Technological advances in genetic engineering and synthetic biology lead to a fast-growing number of purposes such as biofuels, new drugs, replacement organs, and biological threats. The democratisation of such technologies, coupled with the decreasing cost of DNA synthesis, will allow a broader set of actors to generate new organisms, fuelling the
need for addressing individual and societal challenges, while raising concerns about the governance of these technology innovations, capacity-building and benefit sharing. The weaponisation of biology could even lead to high-impact biological attacks that would be difficult to defend against. In this context, it is essential that policymakers and regulators
explore the social, environmental, economic and geopolitical implications of such technology advances.
- At the cusp of an explosion of uses and products, how can we harness the benefits of synthetic cells, biosensors, synthetic organisms and more?
- What effect will synthetic biology applications have on ethics, geopolitics, science policy and society?
Watch this session to hear leading experts present a future significantly shaped by synthetic biology.
Introductory remarks by:
• Jérôme Duberry, Managing Managing Director, Tech Hub; Academic Advisor, INP Executive Education; Senior Researcher, AHCD / CIES, Geneva Graduate Institute, Switzerland
Moderated by:
• Jane Metcalfe, Co-founder, WIRED; Founder, NEO.Life, USA
With:
• Peter Gluckman, President, International Science Council, New Zealand
• Arancha Gonzalez Laya, Dean, SciencePo Paris School of International Studies, Spain
• Andrew Hessel, Chairman, Genome Write-Project; Founder, Humane Genomics, USA
• Timothy Swanson, Professor, International Economics; Academic Co-director, Centre for International Environmental Studies, Geneva Graduate Institute, USA
This session is organised in partnership with the Geneva Graduate Institute.
[ Ссылка ]
